Literature DB >> 26149749

Outbreak of colonization by carbapenemase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Investigation, control measures and assessment.

Jiong Zhou1, Guiping Li1, Xiaojun Ma2, Qiwen Yang3, Jie Yi3.   

Abstract

We describe an outbreak of carbapenemase-producing Klebsiella pneumoniae in a neonatal intensive care unit and assess the effect of infection control measures. Our assessment indicates that active surveillance culture is very useful in identifying multidrug-resistant organisms and its prevention from transmission. Besides contact precaution, environment disinfection, good compliance of hand hygiene, and single-room isolation is very important for preventing transmission of carbapenemase-producing K pneumoniae isolates.
Copyright © 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenemase-producing Klebsiella pneumoniae; Infection control; Neonatal intensive care unit; Outbreak

Mesh：

Substances：

Year:  2015        PMID： 26149749     DOI： 10.1016/j.ajic.2015.05.038

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  10 in total

1.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 2.  Outbreaks in the neonatal ICU: a review of the literature.

Authors:  Julia Johnson; Caroline Quach
Journal:  Curr Opin Infect Dis       Date:  2017-08       Impact factor: 4.915

3.  Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterales in neonatal patients.

Authors:  Jiansheng Wang; Yuanpeng Lv; Weiwei Yang; Peng Zhao; Changfu Yin
Journal:  BMC Microbiol       Date:  2022-07-12       Impact factor: 4.465

4.  Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China.

Authors:  Bing Zheng; Yingxin Dai; Yang Liu; Weiyang Shi; Erkuan Dai; Yichao Han; Dandan Zheng; Yuetian Yu; Min Li
Journal:  Front Microbiol       Date:  2017-06-13       Impact factor: 5.640

5.  Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai.

Authors:  Dongxing Tian; Fen Pan; Chun Wang; Yan Sun; Hong Zhang
Journal:  Infect Drug Resist       Date:  2018-10-24       Impact factor: 4.003

6.  Resistance Trends of Klebsiella pneumoniae Causing Urinary Tract Infections in Chongqing, 2011-2019.

Authors:  Shifeng Huang; Siqiang Niu; Yanhui Ding; Huijuan Wang; Shuli Pu
Journal:  Infect Drug Resist       Date:  2021-02-09       Impact factor: 4.003

7.  Homology analysis between clinically isolated extraintestinal and enteral Klebsiella pneumoniae among neonates.

Authors:  Chun-Mei Chen; Min Wang; Xian-Ping Li; Peng-Ling Li; Jing-Jing Tian; Kan Zhang; Can Luo
Journal:  BMC Microbiol       Date:  2021-01-11       Impact factor: 3.605

8.  Carbapenem-resistant Enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, China.

Authors:  L Yin; L He; J Miao; W Yang; X Wang; J Ma; N Wu; Y Cao; C Wang
Journal:  Infect Prev Pract       Date:  2021-05-12

9.  Emergence of Klebsiella pneumoniae ST307 Co-Producing CTX-M with SHV and KPC from Paediatric Patients at Shenzhen Children's Hospital, China.

Authors:  Sandip Patil; Hongyu Chen; Chunna Guo; Xiaoli Zhang; Pei-Gen Ren; Ngiambudulu M Francisco; Feiqiu Wen
Journal:  Infect Drug Resist       Date:  2021-09-02       Impact factor: 4.003

10.  Risk Factors Affecting Clinical Outcome in Patients with Carbapenem-Resistant K. pneumoniae: A Retrospective Study.

Authors:  Gefei He; Juanjuan Huang; Shiqiong Huang; Ji Sun; Yulv Zhou; Hong Tan; Hui Shen; Zhuan Li; Jiyang Liu
Journal:  Med Sci Monit       Date:  2020-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.